PROCARBAZINE HYDROCHLORIDE IN CHILDHOOD CANCER

被引：10

作者：

BILLMEIER, GJ

HOLTON, CP

机构：

[1] St. Jude Children's Research Hospital, Memphis, TN

[2] The University of Tennessee Medical Units, Memphis, TN

来源：

JOURNAL OF PEDIATRICS | 1969年 / 75卷 / 05期

关键词：

D O I：

10.1016/S0022-3476(69)80319-7

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The therapeutic and toxic effects of procarbazine hydrochloride (Ro-4-6467, Natulan) were assessed in 38 children with neoplastic disease resistant to conventional forms of chemotherapy. The durg was administered orally in a daily dosage of 125 mg. per square meter, to an average total dosage of 5 Gm. per square meter. Objective improvement was seen in 5 of 7 patients with advanced Hodgkin's disease. Median duration of objective response was 13 weeks. No improvement was observed in 8 patients with acute leukemia, 3 patients with lymphosarcoma, and 17 patients with various solid tumors. Toxic manifestations included nausea, vomiting, and depression of normal hematopoiesis. Procarbazine is an effective agent in the treatment of advanced Hodgkin's disease in childhood. © 1969 The C. V. Mosby Company.

引用

页码：892 / +

页数：1

共 13 条

[1] DEGRADATION OF DEOXYRIBONUCLEIC ACID BY NEW TUMOUR INHIBITING COMPOUNDS - INTERMEDIATE FORMATION OF HYDROGEN PEROXIDE [J].

BERNEIS, K ;

BOLLAG, W ;

LANGEMANN, A ;

KOFLER, M ;

KAISER, A .

EXPERIENTIA, 1963, 19 (03) :132-&

[2] TUMOUR INHIBITORY EFFECTS OF A NEW CLASS OF CYTOTOXIC AGENTS - METHYLHYDRAZINE DERIVATIVES [J].

BOLLAG, W ;

GRUNBERG, E .

EXPERIENTIA, 1963, 19 (03) :130-&

[3]

BRULE G, 1965, Cancer Chemother Rep, V44, P31

[4] A METHYLHYDRAZINE DERIVATIVE IN HODGKINS DISEASE AND OTHER MALIGNANT NEOPLASMS - THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS [J].

BRUNNER, KW ;

YOUNG, CW .

ANNALS OF INTERNAL MEDICINE, 1965, 63 (01) :69-+

[5]

DEVITA VT, 1966, CLIN PHARMACOL THER, V7, P542

[6]

GALE GR, 1967, CANCER RES, V27, P1186

[7]

HANSEN MM, 1966, ACTA MED SCAND, V180, P211

[8]

MARTZ G, 1963, CANCER CHEMOTH REP, P5

[9]

MATHE G, 1963, LANCET, V2, P1077

[10]

SAMUELS ML, 1967, CANCER, V20, P1187, DOI 10.1002/1097-0142(196708)20:8<1187::AID-CNCR2820200802>3.0.CO

← 1 2 →